Medical Affairs, Bavarian Nordic AG, 6301 Zug, Switzerland.
J Travel Med. 2022 Jul 14;29(4). doi: 10.1093/jtm/taac027.
Different market share values for TBE vaccines in Austria are reported during the period 2018–2020. However, both data likely cover a significant under-estimation of doses distributed. Thus, for epidemiological evaluations, market share should be used with prudence and only reported when solid whole-market market share can be validated and referenced.
2018 年至 2020 年期间,奥地利报告了 TBE 疫苗的不同市场份额值。然而,这两种数据都可能严重低估了分发的剂量。因此,在进行流行病学评估时,应谨慎使用市场份额,并且只有在可以验证和参考整个市场的完整市场份额时,才能报告市场份额。